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1. Introduction
  Dengue has become an important public health concern 
all over the world since the 1950s[1,2]. Particularly, the 
disease is growing most rapidly in tropical and subtropical 
countries where majority of the world’s population resides 
and increasing health and economic burden[3,4]. Dengue 
is considered to be the predominant vector-borne disease 
in terms of the number of human infections occurring 
globally[5]. However, neither vaccines nor specific treatment 
for DF/DHF are currently available[1,6]. The disease is caused 
by four serotypes (viz. DENV-1, DENV-2, DENV-3, and 
DENV-4) of the genus Flavivirus and transmitted mainly 
by the mosquito Aedes aegypti (Ae. aegypti) though other 
species such as Aedes albopictus (Ae. albopictus) can also 
be vectors of  dengue virus transmission[7,8]. The symptoms 
of the disease range from a non-specific febrile illness, 
muscle and bone pain [as in dengue Fever (DF)] to a more 
severe illness with bleeding tendency, thrombocytopenia, 
severe headache and plasma leakage [dengue hemorrhagic 
fever (DHF)][9]. In recent decades, DHF has become a major 
cause of hospitalization and death among children in most 
of the Asian countries[10]. Dengue is found mainly in urban 
and semi-urban areas of the tropical and subtropical 
regions and people from all income levels (e.g. rich and 
poor) within the endemic regions suffer from morbidity 
and mortality of the disease. The incidence of dengue has 
increased by 30 fold, parallel with increasing dramatically 
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its geographical range and shortening its epidemic cycle in 
many places during the past 50 years[11,12]. Currently, it was 
estimated that dengue is endemic in 124 countries of the 
world, 50 million clinical DF cases worldwide every year, 
2.1 million cases of DHF, and approximately 21 000 deaths 
each year[13]. In Asia Pacific region, approximately, 200 000 
dengue cases have been reported annually during the last 
decade[14]. It was also reported that the disease causes an 
estimated annual loss of 750 000 disability-adjusted-life-
years[15]. Dengue imposes great economic burden on public 
health care system, households affected by the disease and 
society at large in the endemic regions.
  South-east Asia and the Western Pacific are the most 
seriously affected regions by dengue[10]. Tropical regions in 
Asia are acutely vulnerable to the disease. In Malaysia with 
a population of 28.33 million and a population density of 86 
per square kilometer, dengue is currently a highly endemic 
disease[16]. The country has continuously recorded an 
increased number of dengue cases every year since 1980[17]. 
The disease has been declared as one of the national 
health threat to the public in Malaysia[18]. The dengue 
incidence is prevalent throughout the country with the 
highest incidence among the most developed and densely 
populated territories and states. All age group are affected 
with the most vulnerable among the school going children 
and young adults. All ethnic groups are at risk of being 
infected[19]. Changes in climate factors such as temperature 
rising, increased rainfall, and relative humidity are the 
most influential driving forces of dengue transmission 
and intensity in Malaysia[20,21]. During Malaysia’s rapid 
industrialization and economic growth in the past several 
decades, massive infrastructure development resulted in 
spread of the disease[22-24]. The study also reported that the 
continuous process of urbanization has resulted in increased 
incidence of dengue in Malaysia. A recent study reveals 
that dengue has spread from urban city centers to the more 
rural populations of Malaysia, including to the forest fringe 
areas where majority of the aboriginal populations resides 
(AbuBakar S and Lim YAL, 2011). All four dengue virus 
serotypes (viz. DENV-1, DENV-2, DENV-3, and DENV-4) 
have been associated with DF and DHF in Malaysia[25]. 
Although there is a perceived increase in the incidences of 
DF/DHF in Malaysia, the ongoing burden of the disease is 
not well studied. This paper analyses the trends of dengue 
incidences and deaths due to the disease in Malaysia 
from 2000 to 2010 as well as the predominant dengue virus 
serotypes during the last decade. 
2. Materials and methods
  The present study used the national data on annual 
reported cases, deaths, incidence rate, mortality rate, and 
case fatality rate of DF and DHF as well as dengue virus 
serotypes prevalent in Malaysia during the last decade 
(2000-2010). Reported cases included all reported clinical 
cases of DF and DHF. Data were extracted from annual 
health fact sheets published by the Ministry of Health, 
Malaysia and reports on annual dengue data published by 
the Western Pacific Regional Office of the World Health 
Organization over a cumulative period of last 11 years. 
Trend/regression lines were fitted to investigate the trend of 
dengue incidences and deaths due to the disease in Malaysia 
during the last decade. For the distribution of national 
incidence rate, mortality rate, and case fatality rate of DF 
and DHF in Malaysia between 2000 and 2010, descriptive 
statistics using mean and 95% confidence intervals (CI) for 
means, and range were applied. The identity and proportions 
of dengue virus serotypes circulating in each year between 
2004 and 2010 were compared to assess the predominant 
serotypes of dengue virus in Malaysia. Findings of the study 
were presented in tabular and graphical format. 
3. Results 
3.1. Trend of dengue incidence
  Figure 1 shows the annual number of reported dengue 
(including DHF) cases and the trend of dengue incidences 
in Malaysia during this decade. It can be seen that the 
incidence of the disease has increased seven-fold over the 
period 2000-2010. In the year 2000, the number of reported 
dengue cases was 7 103. However, more than 30 000 cases 
have been reported every year from 2002 to 2006. The 
country experienced the greatest burden of the disease (on 
average 48 500 cases) in 2007 and 2008 culminating with 
the highest number of 49 335 cases in the year 2008. The 
annual number of reported dengue cases dropped to 41 486 
in the year 2009. But, in 2010, an increase in the number 
of reported dengue cases has been notified, making 2010 
another worse year on record. The findings reveal that there 
is an overall escalating trend in annual incidences of dengue 
in Malaysia in recent years though there are ups and downs 
in the trend. The exponential curve fitted to these data shows 
an average increase in dengue incidence of 13.92% per year. 
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Figure 1. Reported dengue (including DHF) cases in Malaysia (2000-
2010).
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3.2. Trend of deaths due to dengue
  The annual number of deaths due to dengue (including 
DHF) in Malaysia between 2000 and 2010 has been presented 
in Figure 2. The data show a noteworthy fluctuation in 
annual deaths due to the disease. The number of reported 
deaths in the year of highest mortality (134 deaths) is three 
times the number reported for in the lowest year (45 deaths). 
In 2000 and 2001, an average of 48 deaths due to dengue was 
reported annually. However, a remarkable variation was 
observed in the subsequent two years-99 deaths in 2002 and 
72 in year 2003. The annual number of reported deaths due 
to the disease exceeded 100 in years 2004, 2005, and 2008. 
But the disease took its highest toll (134 deaths) in the last 
year of the decade. The trend line fitted in Figure 2 confirms 
a general upward trend in the reported number of deaths 
due to dengue in Malaysia in recent years. The findings 
revealed that the number of deaths due to dengue increased 
by, on average, 7.79% per year between 2000 and 2010 in the 
country. 
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Figure 2. Reported deaths due to dengue (including DHF) in Malaysia 
(2000-2010).
3.3. Distribution of incidence rate, mortality rate, and case 
fatality rate
  The study computed and compared yearly distribution of 
incidence rate and mortality rate of DF with that of DHF 
in Malaysia during 2000-2010. It was found that the mean 
incidence rate of DF per 100 000 populations per year was 
84.71 with lower limit of 54.39 and upper limit of 115.02 (95% 
CI). Conversely, the annual incidence rate of DHF per 100 000
populations was, on average, 5.99 (with 95% CI=3.33-8.64). 
The findings indicate that annual number of DF cases in 
every 100 000 populations was much greater than that of DHF 
cases in Malaysia between 2000 and 2010. Moreover, the 
ranges of yearly incidence rate of DF and DHF suggest that 
there was a greater variation in annual number of DF cases 
as compared to DHF cases. However, the findings showed 
the opposite scenario in mortality rate of DF and DHF in the 
last 11-year period. The average mortality rate of DF per 
100 000 populations per year was 0.06 with 95% CI of 0.00-
0.12. On the other hand, the annual mortality rate of DHF 
per 100 000 populations was, on average, 0.30 with the lower 
limit of 0.24 and upper limit of 0.35. The findings reveal that 
the annual number of deaths due to DHF in every 100 000 
populations was greater than that of DF. The yearly case 
fatality rate of DF/DHF in the country between 2000 and 2010 
was, on average, 0.29 with the lower limit of 0.21 and the 
upper limit of 0.37. 
3.4. Dengue virus serotypes
  In Malaysia, all four dengue virus serotypes (viz. DEN-1, 
DEN-2, DEN-3 and DEN-4) were prevalent in almost every 
year of the last decade. The most frequently circulating 
serotype in 2004 was DEN-1(73.4%), followed by DEN-3 
(14.6%), DEN-2 (7.4%), and DEN-4 (4.6%). Similarly, in 2005, 
the predominant circulating serotype was DEN-1 (58.6%) 
while the other major serotypes were DEN-3 (17.1%), DEN-2 
(8.4%), and DEN-4 (1.2%). But this pattern changed during 
the next two years when DEN-2 (36.4%) was the predominant 
serotype in 2006 followed by DEN-1 (33.0%), DEN-3 (19.3%), 
and DEN-4 (4.5%). Also in the year 2007, DEN-2 was the 
most frequently circulating serotype (53.0%). Dengue virus 
type 1 (DEN-1) was the other major serotype (30.0%) in that 
year and followed by DEN-3 (11.0%), and DEN-4 (6.0%). It 
is important to note that dengue virus type 4 (DEN-4) was 
reported as the least common serotype which accounted 
to more or less 5% of all dengue virus isolated in Malaysia 
during the period 2004- 2007. Dengue virus type 1 and 4 
(DEN-1 and DEN-4) was no longer commonly isolated in 
the year 2009 and the co-circulation of only DEN-2 and 
DEN-3 was documented in the country. However, DEN-1 
and DEN-4 were reintroduced in the year 2010. Though all 
four serotypes were co-circulated in 2010, none of them had 
been revealed as the predominant serotype. 
4. Discussion
  Dengue infection showed a rising trend in the Western 
Pacific Region including Malaysia in the past few years 
though there was a great variation in incidence of the 
disease from year to year[14]. In Ho Chi Minh City, Vietnam, 
132 480 clinically diagnosed dengue fever cases were 
reported between 1996 and 2009[26]. A total of 385 758 dengue 
cases (including DHF) were reported in Malaysia from 
2000 to 2010. Examination of cumulative data on each year 
revealed a clear exponential increase in the incidences of 
DF/DHF in the country in recent years. The exponential 
increase in the incidences of the disease is a cause for 
concern. The high endemicity of dengue in Malaysia could 
be due to demographic changes, massive urbanization in 
town areas, changes in the usage of agricultural land in rural 
areas, and lack of effective mosquito control programs[17,27]. 
The widespread distribution and rising incidence of dengue 
infections accounted for increased dengue-related mortality 
in Malaysia. The country reported a total of 997 deaths 
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due to dengue during the last decade. There was also an 
overall rising trend in the reported deaths due to the disease 
between 2000 and 2010.
  The study also focuses on the distribution of national 
incidence rate, mortality rate and case fatality rate of DF/
DHF in Malaysia as such type of data are easily comparable 
and thus more informative. There was a heterogeneous 
distribution of DF/DHF in the country during the last 
decade. The yearly average mortality rate of DHF was much 
higher than that of DF. This implies that a greater portion 
of total dengue-related deaths in the country was due to 
DHF. It also reflects the emergence of a more virulent, DHF 
prone dengue virus in the country. Similarly, the annual 
averages of morbidity rate, mortality rate and case fatality 
rate of DF/ DHF in Myanmar were significantly different for 
the period 1991-2001[28]. In Cambodia, case fatality rate of 
dengue fever ranged from 0.7% to 1.7% in the period 2002-
2008[29-32]. However, in Malaysia, the overall case fatality 
rate of DF/DHF in 2000s was lower (0.29) as compared to that 
(0.55) in 1990s[33]. The decline in case fatality rate of DF/DHF 
can be attributed to a number of factors such as increasing 
awareness of the people about dengue and better patient 
management of the health system. The incidence, mortality, 
and case fatality of dengue are affected by the dengue 
virus serotypes circulating for a particular time period. The 
simultaneous circulation of all four dengue serotypes has 
been found in Malaysia during the last decade. The previous 
studies also found the co-circulation of all four serotypes 
in the country in 1990s and 1980s[33,34]. It is important to 
note that a particular dengue virus serotype predominates 
for at least two years before it becomes replaced by another 
serotype. It is also noted that the co-circulation of more 
than one serotype favors the occurrence of more cases of 
secondary infection and consequently an increase in the risk 
of DHF/dengue shock syndrome (DSS)[35]. 
  In conclusion, the dengue situation in Malaysia has 
worsened with an increasing number of reported cases and 
deaths during the last decade. The number of dengue cases 
and number of deaths due to the disease have increased, 
on average, by 14% and 8% per year respectively between 
2000 and 2010. These findings indicate the recent increase 
in outbreak and severity of the disease in the country. 
Though public health authorities have taken numerous 
efforts and strategies to prevent and control dengue, the 
increasing incidence of the disease highlights the need for 
a more systematic surveillance and prediction of the ever-
evolving epidemiology of the disease. To make dengue 
surveillance and prediction more systematic and effective, 
trend assessment of the disease should continue to be 
essential both at local as well as national level. Moreover, 
trend analysis of dengue incidences could assist public 
health authorities in improving vector control to minimize 
the ongoing burden of the disease in the country. 
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